Skip navigation
The HCPC will be closed from 12 noon on 24 December 2024, reopening 2 January 2025. Email inboxes and phones are not being monitored. More information

Canlyniadau chwilio am registration certificate

Yn dangos 316 i 330 o 613 canlyniadau

Partner recruitment statistics - last six months

We have had a busy six months recruiting for various HCPC partner roles and have been very successful to fill nearly all our vacancies. A very warm welcome to all our new partners!

Executive Leadership Team (ELT)

The ELT has day-to-day responsibility for managing HCPC

Company and business names

Applying for non-objection when using protected titles in company names

Guidance on health and character

This document provides guidance on our processes when assessing the health and character of people who apply to, or who are on, our Register.

Paramedic prescribing: what you need to know

New legislation has come into force to allow advanced paramedics to prescribe medicines to patients. As of 1 April 2018, paramedics were able to undertake training in independent and supplementary prescribing.

Declaration

You’ll be asked to sign a declaration regarding background checks to enable us to check that they are genuine with the organisations or individuals who provided them

Statement on physiotherapist renewals

Statement on physiotherapist renewals from Andrew Smith, Executive Director of Regulation

New eLearning modules for Partners

We have released new eLearning modules to support your development in your role and inform you about changes in our standards.

Physiotherapists: how to rejoin the Register if you’ve been removed

We want to get you back on the Register as soon as possible. Please follow these steps to make sure you've reapplied correctly. 

COVID-19 advice for students

We have opened a temporary register for final year students who have completed their placement learning

My story - Nana-Jane Chipampe

Nana-Jane is a registered biomedical scientist currently in the third year of her PhD researching Bladder Cancer.

Regulating in the next phase – COVID-19

The pandemic required us to quickly adapt how we operated as a regulator. We intend to build on this agility to ensure we deliver effective public protection through lean and intelligent regulation.

Top